論文

査読有り
2006年7月

Gene therapeutics: the future of brain tumor therapy?

EXPERT REVIEW OF ANTICANCER THERAPY
  • Jennifer L. Cutter
  • ,
  • Kazuhiko Kurozumi
  • ,
  • E. Antonio Chiocca
  • ,
  • Balveen Kaur

6
7
開始ページ
1053
終了ページ
1064
記述言語
英語
掲載種別
DOI
10.1586/14737140.6.7.1053
出版者・発行元
FUTURE DRUGS LTD

Primary glioblastoma multiforme is an aggressive brain tumor that has no cure. Current treatments include gross resection of the tumor, radiation and chemotherapy. Despite valiant efforts, prognosis remains dismal. A promising new technique involves the use of oncolytic viruses that can specifically replicate and lyse in cancers, without spreading to normal tissues. Currently, these are being tested in relevant preclinical models and clinical trials as a therapeutic modality for many types of cancer. Results from recent clinical trials with oncolytic viruses have revealed the safety of this approach, although evidence for efficacy remains elusive. Oncolytic viral strategies are summarized in this review, with a focus on therapies used in brain tumors.

リンク情報
DOI
https://doi.org/10.1586/14737140.6.7.1053
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/16831077
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000240923300016&DestApp=WOS_CPL
ID情報
  • DOI : 10.1586/14737140.6.7.1053
  • ISSN : 1473-7140
  • PubMed ID : 16831077
  • Web of Science ID : WOS:000240923300016

エクスポート
BibTeX RIS